HCV treatment with sofosbuvir in Pakistan; current scenario and future perspective

Simple item page
dc.contributor.authorAyesha Khaliq
dc.contributor.authorImtiaz Ahmad
dc.contributor.authorMuhammad Sohail Afzal
dc.date.accessioned2019-07-09T11:38:33Z
dc.date.available2019-07-09T11:38:33Z
dc.date.issued2018
dc.description.abstractHepatitis C Virus (HCV) is a global problem with around 1.75 million new infections yearly. With approximate 70% chronicity rate about 399,000 people die each year from hepatitis C. Pakistan is endemic for this infection with 5-8% prevalence in general population. There are several HCV genotypes and antiviral therapies are genotype dependent. In Pakistan genotype 3a is dominant followed by diagnostically untypable HCV variants. Previously interferon based antiviral regimens were the only choice for HCV treatment in Pakistan. Recently sofosbuvir is introduced in Pakistan on heavily discount. Although sofosbuvir showed very good sustained virological response (SVR) globally but due to different ethnicity and genetic makeup, it is important to analyse the drug efficacy in Pakistan. Available limited data showed that overall SVR/rapid virological response (RVR) is very good. The current data is very limited and it is highly needed to have studies reporting the sofosbuvir treatment response from different ethnic groups from the whole country.en_US
dc.identifier.citationAfzal, M. S., & Ahmad, I. (2018). HCV Treatment with Sofosbuvir in Pakistan; Current Scenario and Future Perspective. Journal of Gastroenterology and Hepatology Research, 7(2), 2578-2580.en_US
dc.identifier.urihttps://escholar.umt.edu.pk/handle/123456789/3752
dc.language.isoenen_US
dc.publisherournal of Gastroenterology and Hepatology Researchen_US
dc.subjectHCV; Treatment; Sofosbuvir; Direct acting antivirals; Pakistanen_US
dc.titleHCV treatment with sofosbuvir in Pakistan; current scenario and future perspectiveen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
HCV Treatment with Sofosbuvir in Pakistan; Current Scenario and Future Perspective.pdf
Size:
129.62 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Department of Life Sciences